
PipingRock Ginkgo Biloba, Enhances Cognitive Function, Memory & Circulation, Capsules - 100 Count
100 capsules
We'll send you a WhatsApp message when this product is back in stock
About this product
PipingRock Ginkgo Biloba 120mg is a premium herbal supplement designed to support cognitive function and healthy blood circulation.
- Enhances memory, concentration, and overall cognitive performance.
- Promotes optimal blood flow to the brain and extremities.
- Features a potent 120mg dose of high-quality Ginkgo Biloba extract per capsule.
- Ideal for individuals experiencing age-related memory decline or seeking circulatory support.
How to use
How to Use:
- Take 1 capsule daily, preferably with a meal.
- Do not exceed the recommended dosage.
- Consult a healthcare professional before use if pregnant, nursing, taking anticoagulant or antiplatelet medications, or have bleeding disorders.
- Discontinue use two weeks prior to any surgery.
Warnings:
- Individuals on anticoagulant therapy or with bleeding disorders should consult a physician before use.
- Potential side effects include headache, dizziness, gastrointestinal upset, and allergic skin reactions.
Frequently asked questions
What is Ginkgo Biloba 120mg?
It is a dietary supplement containing Ginkgo Biloba extract, an herb used to support memory, concentration, and improve blood circulation.
What are the benefits of Ginkgo Biloba?
It helps enhance memory and concentration, supports healthy blood circulation to the brain and extremities, and may be beneficial for conditions like tinnitus and vertigo.
How do I use Ginkgo Biloba?
Take one capsule daily with a meal. Do not exceed the recommended dose and consult your doctor if you are on other medications.
Are there any side effects of Ginkgo Biloba?
Common side effects may include headache and digestive upset. There is a rare risk of increased bleeding, especially with blood-thinning medications.
Related products

BRONSON Ginkgo Biloba for Cognitive Function Support, Capsules - 60 Count
Customer reviews
Reviews
No reviews yet


